Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cornea | 24 | 2022 | 1497 | 3.050 |
Why?
|
Burns, Chemical | 9 | 2020 | 154 | 2.910 |
Why?
|
Corneal Diseases | 16 | 2022 | 615 | 2.500 |
Why?
|
Eye Burns | 7 | 2020 | 102 | 2.360 |
Why?
|
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 3 | 2021 | 110 | 2.110 |
Why?
|
Artificial Organs | 9 | 2020 | 204 | 2.110 |
Why?
|
Eye Injuries | 3 | 2023 | 245 | 1.780 |
Why?
|
Retina | 8 | 2020 | 2611 | 1.660 |
Why?
|
Microglia | 5 | 2021 | 1261 | 1.590 |
Why?
|
Prostheses and Implants | 17 | 2023 | 1385 | 1.500 |
Why?
|
Monocytes | 5 | 2023 | 2593 | 1.490 |
Why?
|
Retinal Diseases | 6 | 2019 | 683 | 1.440 |
Why?
|
Neuroglia | 3 | 2020 | 925 | 1.390 |
Why?
|
Glaucoma | 7 | 2022 | 1152 | 1.310 |
Why?
|
Intraocular Pressure | 11 | 2020 | 1274 | 1.230 |
Why?
|
Corneal Neovascularization | 3 | 2020 | 188 | 1.190 |
Why?
|
Astigmatism | 2 | 2020 | 70 | 1.170 |
Why?
|
Tumor Necrosis Factor-alpha | 9 | 2023 | 4414 | 1.050 |
Why?
|
Blepharoptosis | 3 | 2023 | 144 | 1.030 |
Why?
|
Titanium | 4 | 2020 | 494 | 1.010 |
Why?
|
Organic Chemicals | 2 | 2021 | 211 | 0.880 |
Why?
|
Keratomileusis, Laser In Situ | 3 | 2011 | 88 | 0.790 |
Why?
|
Artificial Limbs | 1 | 2022 | 123 | 0.780 |
Why?
|
Hyperopia | 2 | 2011 | 44 | 0.770 |
Why?
|
Rabbits | 8 | 2020 | 4886 | 0.770 |
Why?
|
Lasers, Excimer | 3 | 2011 | 72 | 0.770 |
Why?
|
Glaucoma, Angle-Closure | 2 | 2019 | 189 | 0.710 |
Why?
|
Refractive Surgical Procedures | 1 | 2019 | 25 | 0.710 |
Why?
|
Myopia | 3 | 2011 | 254 | 0.710 |
Why?
|
Corneal Stroma | 2 | 2011 | 170 | 0.710 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 2 | 2019 | 357 | 0.690 |
Why?
|
Optic Nerve Injuries | 1 | 2018 | 151 | 0.600 |
Why?
|
Glaucoma Drainage Implants | 2 | 2019 | 116 | 0.570 |
Why?
|
Sterilization | 4 | 2021 | 134 | 0.570 |
Why?
|
Blepharoplasty | 2 | 2014 | 50 | 0.520 |
Why?
|
Retinal Degeneration | 2 | 2018 | 414 | 0.510 |
Why?
|
Macrophages | 5 | 2023 | 5655 | 0.490 |
Why?
|
Gamma Rays | 5 | 2021 | 320 | 0.490 |
Why?
|
Hematopoiesis | 2 | 2021 | 2066 | 0.480 |
Why?
|
Tonometry, Ocular | 4 | 2020 | 237 | 0.480 |
Why?
|
Prosthesis Coloring | 1 | 2013 | 31 | 0.460 |
Why?
|
Corneal Wavefront Aberration | 1 | 2013 | 6 | 0.450 |
Why?
|
Aberrometry | 1 | 2013 | 6 | 0.450 |
Why?
|
Nose Deformities, Acquired | 1 | 2013 | 44 | 0.450 |
Why?
|
Small Molecule Libraries | 1 | 2018 | 721 | 0.440 |
Why?
|
Polymethyl Methacrylate | 4 | 2021 | 145 | 0.430 |
Why?
|
Keratoplasty, Penetrating | 4 | 2022 | 154 | 0.430 |
Why?
|
Corneal Transplantation | 3 | 2021 | 368 | 0.430 |
Why?
|
Surgical Flaps | 2 | 2011 | 1634 | 0.420 |
Why?
|
Prosthesis Implantation | 5 | 2020 | 641 | 0.420 |
Why?
|
Visual Acuity | 9 | 2020 | 2520 | 0.400 |
Why?
|
Glaucoma, Open-Angle | 5 | 2021 | 711 | 0.390 |
Why?
|
Magnetite Nanoparticles | 1 | 2013 | 322 | 0.390 |
Why?
|
Retinal Ganglion Cells | 5 | 2019 | 771 | 0.390 |
Why?
|
Lipectomy | 2 | 2014 | 118 | 0.390 |
Why?
|
Hyaluronic Acid | 1 | 2013 | 489 | 0.360 |
Why?
|
Rhinoplasty | 1 | 2013 | 226 | 0.350 |
Why?
|
Neurodegenerative Diseases | 1 | 2018 | 1060 | 0.350 |
Why?
|
Cytokines | 4 | 2021 | 7317 | 0.340 |
Why?
|
Cell Adhesion | 1 | 2016 | 3139 | 0.340 |
Why?
|
Disease Models, Animal | 7 | 2020 | 18006 | 0.320 |
Why?
|
Tomography, Optical Coherence | 6 | 2020 | 2637 | 0.300 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 2 | 2019 | 264 | 0.290 |
Why?
|
Interleukin-1beta | 4 | 2020 | 972 | 0.290 |
Why?
|
Limbus Corneae | 2 | 2018 | 142 | 0.270 |
Why?
|
Cell Proliferation | 3 | 2016 | 10472 | 0.260 |
Why?
|
Endophthalmitis | 2 | 2020 | 263 | 0.250 |
Why?
|
Animals | 22 | 2021 | 168561 | 0.250 |
Why?
|
Oculomotor Muscles | 2 | 2022 | 371 | 0.240 |
Why?
|
Epithelium, Corneal | 2 | 2017 | 241 | 0.240 |
Why?
|
Endothelium, Corneal | 2 | 2016 | 147 | 0.230 |
Why?
|
Optic Nerve Diseases | 2 | 2017 | 327 | 0.220 |
Why?
|
Optic Disk | 2 | 2017 | 401 | 0.220 |
Why?
|
Aqueous Humor | 2 | 2013 | 161 | 0.210 |
Why?
|
Descemet Stripping Endothelial Keratoplasty | 1 | 2022 | 61 | 0.200 |
Why?
|
Complement C5 | 1 | 2021 | 111 | 0.190 |
Why?
|
Mice, Inbred C57BL | 8 | 2020 | 21821 | 0.190 |
Why?
|
Fusarium | 1 | 2020 | 51 | 0.190 |
Why?
|
Neuroprotective Agents | 2 | 2018 | 941 | 0.190 |
Why?
|
Bruch Membrane | 2 | 2017 | 64 | 0.190 |
Why?
|
Surface Properties | 3 | 2021 | 1182 | 0.190 |
Why?
|
Sodium Hydroxide | 2 | 2017 | 43 | 0.180 |
Why?
|
Receptors, Chemokine | 1 | 2023 | 669 | 0.180 |
Why?
|
Gonioscopy | 1 | 2020 | 157 | 0.180 |
Why?
|
Nerve Fibers | 2 | 2016 | 688 | 0.180 |
Why?
|
Gelatin | 1 | 2021 | 225 | 0.180 |
Why?
|
Aspergillus fumigatus | 1 | 2020 | 150 | 0.170 |
Why?
|
Aniridia | 1 | 2019 | 36 | 0.170 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2020 | 293 | 0.170 |
Why?
|
Blindness | 2 | 2020 | 615 | 0.160 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2020 | 772 | 0.160 |
Why?
|
Prosthesis Design | 3 | 2020 | 2110 | 0.160 |
Why?
|
N-Methylaspartate | 1 | 2019 | 231 | 0.160 |
Why?
|
Blood Sedimentation | 1 | 2019 | 231 | 0.160 |
Why?
|
Mice | 10 | 2020 | 81045 | 0.150 |
Why?
|
Uvea | 1 | 2017 | 31 | 0.150 |
Why?
|
Carbonic Anhydrase Inhibitors | 1 | 2018 | 95 | 0.150 |
Why?
|
Candida albicans | 1 | 2020 | 394 | 0.150 |
Why?
|
Alkalies | 1 | 2017 | 52 | 0.150 |
Why?
|
Disinfection | 1 | 2019 | 191 | 0.150 |
Why?
|
Humans | 44 | 2023 | 742088 | 0.150 |
Why?
|
Magnetic Field Therapy | 1 | 2017 | 28 | 0.150 |
Why?
|
Low Tension Glaucoma | 1 | 2016 | 22 | 0.140 |
Why?
|
Uveitis, Anterior | 1 | 2017 | 101 | 0.140 |
Why?
|
Fibroblasts | 3 | 2021 | 4143 | 0.140 |
Why?
|
Posterior Eye Segment | 1 | 2016 | 14 | 0.140 |
Why?
|
Anterior Eye Segment | 1 | 2017 | 153 | 0.140 |
Why?
|
GTPase-Activating Proteins | 1 | 2019 | 497 | 0.140 |
Why?
|
Drug Implants | 1 | 2017 | 243 | 0.140 |
Why?
|
Species Specificity | 1 | 2020 | 2479 | 0.140 |
Why?
|
Tissue Scaffolds | 2 | 2021 | 957 | 0.140 |
Why?
|
Antifungal Agents | 1 | 2020 | 729 | 0.140 |
Why?
|
Electrons | 3 | 2021 | 268 | 0.130 |
Why?
|
Hemianopsia | 1 | 2017 | 122 | 0.130 |
Why?
|
Antibiotic Prophylaxis | 1 | 2020 | 638 | 0.130 |
Why?
|
Models, Animal | 2 | 2019 | 2170 | 0.130 |
Why?
|
Mice, Mutant Strains | 1 | 2018 | 1866 | 0.130 |
Why?
|
Complement Pathway, Alternative | 1 | 2015 | 126 | 0.130 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2017 | 2552 | 0.130 |
Why?
|
Phagocytosis | 1 | 2020 | 1538 | 0.120 |
Why?
|
Cicatrix | 1 | 2020 | 761 | 0.120 |
Why?
|
Filtering Surgery | 1 | 2014 | 35 | 0.120 |
Why?
|
Inflammasomes | 1 | 2019 | 493 | 0.120 |
Why?
|
Materials Testing | 2 | 2018 | 865 | 0.120 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2019 | 3862 | 0.120 |
Why?
|
Photoreceptor Cells, Vertebrate | 1 | 2015 | 204 | 0.120 |
Why?
|
Cogan Syndrome | 1 | 2013 | 11 | 0.110 |
Why?
|
Delayed-Action Preparations | 1 | 2017 | 965 | 0.110 |
Why?
|
Conjunctiva | 1 | 2017 | 493 | 0.110 |
Why?
|
Vitreous Body | 1 | 2015 | 389 | 0.110 |
Why?
|
Biocompatible Materials | 3 | 2021 | 1731 | 0.110 |
Why?
|
Electrochemical Techniques | 1 | 2013 | 98 | 0.110 |
Why?
|
X-Ray Diffraction | 1 | 2013 | 420 | 0.110 |
Why?
|
Feasibility Studies | 1 | 2022 | 5062 | 0.110 |
Why?
|
Corneal Opacity | 1 | 2012 | 59 | 0.110 |
Why?
|
Apraxias | 1 | 2013 | 64 | 0.110 |
Why?
|
Male | 22 | 2020 | 349538 | 0.100 |
Why?
|
Trabecular Meshwork | 1 | 2012 | 98 | 0.100 |
Why?
|
Antigens, CD | 2 | 2020 | 4024 | 0.100 |
Why?
|
Female | 21 | 2020 | 379592 | 0.100 |
Why?
|
Injections, Subcutaneous | 1 | 2013 | 664 | 0.100 |
Why?
|
Esthetics | 1 | 2013 | 306 | 0.100 |
Why?
|
Follow-Up Studies | 7 | 2022 | 39004 | 0.100 |
Why?
|
Retinoblastoma | 1 | 2014 | 318 | 0.100 |
Why?
|
Intravitreal Injections | 1 | 2013 | 345 | 0.100 |
Why?
|
Corneal Topography | 1 | 2011 | 71 | 0.100 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2017 | 1372 | 0.100 |
Why?
|
Nerve Degeneration | 1 | 2016 | 748 | 0.100 |
Why?
|
Bioprosthesis | 1 | 2016 | 596 | 0.100 |
Why?
|
Oxidation-Reduction | 1 | 2017 | 2187 | 0.100 |
Why?
|
Refractive Errors | 1 | 2013 | 142 | 0.100 |
Why?
|
Tissue Engineering | 1 | 2021 | 1877 | 0.100 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2020 | 3502 | 0.100 |
Why?
|
Leptin | 1 | 2019 | 1593 | 0.090 |
Why?
|
Calibration | 1 | 2013 | 815 | 0.090 |
Why?
|
Visual Fields | 1 | 2017 | 1049 | 0.090 |
Why?
|
Refraction, Ocular | 1 | 2011 | 181 | 0.090 |
Why?
|
Postoperative Complications | 4 | 2019 | 15244 | 0.090 |
Why?
|
Scanning Laser Polarimetry | 1 | 2010 | 5 | 0.090 |
Why?
|
Transplantation Immunology | 1 | 2012 | 547 | 0.090 |
Why?
|
Neuronal Plasticity | 1 | 2018 | 1418 | 0.090 |
Why?
|
Microscopy, Confocal | 1 | 2016 | 1969 | 0.090 |
Why?
|
Eye Infections, Bacterial | 1 | 2013 | 235 | 0.090 |
Why?
|
Photorefractive Keratectomy | 1 | 2010 | 38 | 0.090 |
Why?
|
Inflammation Mediators | 1 | 2018 | 1889 | 0.090 |
Why?
|
Cross-Sectional Studies | 6 | 2021 | 24913 | 0.090 |
Why?
|
Autoimmune Diseases | 1 | 2021 | 2130 | 0.090 |
Why?
|
Eye Diseases | 1 | 2015 | 670 | 0.080 |
Why?
|
Neovascularization, Pathologic | 1 | 2019 | 2633 | 0.080 |
Why?
|
Drug Delivery Systems | 1 | 2020 | 2217 | 0.080 |
Why?
|
Stem Cell Transplantation | 1 | 2017 | 1618 | 0.080 |
Why?
|
Extracellular Matrix | 1 | 2016 | 1740 | 0.080 |
Why?
|
Blotting, Western | 1 | 2016 | 5180 | 0.080 |
Why?
|
Middle Aged | 15 | 2020 | 213127 | 0.080 |
Why?
|
Anti-Inflammatory Agents | 1 | 2018 | 1788 | 0.080 |
Why?
|
Diagnostic Techniques, Ophthalmological | 1 | 2010 | 246 | 0.080 |
Why?
|
Mice, Transgenic | 1 | 2020 | 9735 | 0.080 |
Why?
|
Metformin | 1 | 2014 | 829 | 0.080 |
Why?
|
Eyelids | 2 | 2023 | 263 | 0.070 |
Why?
|
Antirheumatic Agents | 1 | 2017 | 1335 | 0.070 |
Why?
|
Retrospective Studies | 9 | 2022 | 77098 | 0.070 |
Why?
|
Cell Movement | 1 | 2018 | 5212 | 0.070 |
Why?
|
Swine | 3 | 2021 | 5934 | 0.070 |
Why?
|
In Situ Nick-End Labeling | 2 | 2019 | 643 | 0.070 |
Why?
|
Reproducibility of Results | 3 | 2016 | 19862 | 0.060 |
Why?
|
Drug Combinations | 2 | 2020 | 1961 | 0.060 |
Why?
|
Aged | 13 | 2020 | 162944 | 0.060 |
Why?
|
Stem Cells | 1 | 2017 | 3563 | 0.060 |
Why?
|
Patient Satisfaction | 2 | 2014 | 3391 | 0.060 |
Why?
|
Imaging, Three-Dimensional | 1 | 2017 | 4029 | 0.060 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2014 | 2276 | 0.060 |
Why?
|
Apoptosis | 2 | 2017 | 9715 | 0.060 |
Why?
|
Inflammation | 2 | 2021 | 10578 | 0.060 |
Why?
|
Adipose Tissue | 1 | 2014 | 3278 | 0.050 |
Why?
|
Cells, Cultured | 2 | 2019 | 19223 | 0.050 |
Why?
|
Young Adult | 6 | 2020 | 56350 | 0.050 |
Why?
|
Mice, Knockout | 1 | 2017 | 14554 | 0.050 |
Why?
|
Cell Death | 2 | 2019 | 1695 | 0.050 |
Why?
|
Thermogravimetry | 1 | 2021 | 9 | 0.050 |
Why?
|
Cell Line | 1 | 2016 | 15994 | 0.050 |
Why?
|
Methacrylates | 1 | 2021 | 107 | 0.050 |
Why?
|
Calorimetry, Differential Scanning | 1 | 2021 | 94 | 0.050 |
Why?
|
Adult | 12 | 2020 | 213712 | 0.050 |
Why?
|
Cell Differentiation | 1 | 2018 | 11470 | 0.050 |
Why?
|
Polymyxin B | 1 | 2020 | 46 | 0.050 |
Why?
|
Pyrrolidinones | 1 | 2021 | 117 | 0.050 |
Why?
|
Epoxy Compounds | 1 | 2021 | 136 | 0.050 |
Why?
|
Benzalkonium Compounds | 1 | 2020 | 24 | 0.050 |
Why?
|
Mice, Inbred BALB C | 3 | 2016 | 6382 | 0.050 |
Why?
|
Spectroscopy, Fourier Transform Infrared | 1 | 2021 | 162 | 0.050 |
Why?
|
Trimethoprim | 1 | 2020 | 91 | 0.050 |
Why?
|
Contact Lenses, Hydrophilic | 1 | 2020 | 64 | 0.050 |
Why?
|
Microscopy, Atomic Force | 1 | 2021 | 248 | 0.050 |
Why?
|
Eye Infections, Fungal | 1 | 2020 | 110 | 0.040 |
Why?
|
Complement Activation | 1 | 2021 | 452 | 0.040 |
Why?
|
Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2019 | 143 | 0.040 |
Why?
|
Ultrasonography | 1 | 2011 | 5978 | 0.040 |
Why?
|
Laminin | 1 | 2019 | 418 | 0.040 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2019 | 599 | 0.040 |
Why?
|
Prospective Studies | 4 | 2017 | 53187 | 0.040 |
Why?
|
Postoperative Period | 2 | 2014 | 1839 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 2014 | 9274 | 0.040 |
Why?
|
Oculomotor Nerve Diseases | 1 | 2017 | 48 | 0.040 |
Why?
|
Exotropia | 1 | 2017 | 55 | 0.040 |
Why?
|
Cost Control | 1 | 2019 | 624 | 0.040 |
Why?
|
Proteoglycans | 1 | 2019 | 834 | 0.030 |
Why?
|
Caspases | 1 | 2019 | 928 | 0.030 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2019 | 664 | 0.030 |
Why?
|
Transplantation, Isogeneic | 1 | 2016 | 257 | 0.030 |
Why?
|
Hydrogels | 1 | 2021 | 723 | 0.030 |
Why?
|
Transplantation, Homologous | 2 | 2016 | 4771 | 0.030 |
Why?
|
Stress, Mechanical | 1 | 2021 | 1684 | 0.030 |
Why?
|
Organ Preservation | 1 | 2018 | 324 | 0.030 |
Why?
|
Visual Field Tests | 1 | 2017 | 383 | 0.030 |
Why?
|
Lasers | 1 | 2019 | 952 | 0.030 |
Why?
|
Microbial Sensitivity Tests | 1 | 2020 | 1871 | 0.030 |
Why?
|
Prosthesis Failure | 1 | 2020 | 1203 | 0.030 |
Why?
|
Water | 1 | 2021 | 1388 | 0.030 |
Why?
|
Temperature | 1 | 2021 | 2207 | 0.030 |
Why?
|
Oligopeptides | 1 | 2019 | 1176 | 0.030 |
Why?
|
Injections, Intraperitoneal | 1 | 2014 | 424 | 0.030 |
Why?
|
Rhytidoplasty | 1 | 2014 | 60 | 0.030 |
Why?
|
Enzyme Activation | 1 | 2019 | 3701 | 0.030 |
Why?
|
Imidazoles | 1 | 2019 | 1205 | 0.030 |
Why?
|
Conjunctivitis | 1 | 2014 | 158 | 0.030 |
Why?
|
Diplopia | 1 | 2014 | 199 | 0.030 |
Why?
|
Transplantation, Heterologous | 1 | 2021 | 2382 | 0.030 |
Why?
|
RNA, Messenger | 2 | 2019 | 13029 | 0.030 |
Why?
|
Triamcinolone Acetonide | 1 | 2013 | 101 | 0.030 |
Why?
|
Preoperative Period | 1 | 2014 | 546 | 0.030 |
Why?
|
Aptamers, Nucleotide | 1 | 2013 | 166 | 0.020 |
Why?
|
Exfoliation Syndrome | 1 | 2012 | 111 | 0.020 |
Why?
|
Indoles | 1 | 2019 | 1834 | 0.020 |
Why?
|
Collagen | 1 | 2019 | 2684 | 0.020 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2014 | 608 | 0.020 |
Why?
|
Orbit | 1 | 2014 | 427 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 1 | 2019 | 3770 | 0.020 |
Why?
|
Incidence | 2 | 2022 | 20928 | 0.020 |
Why?
|
Isoantigens | 1 | 2012 | 567 | 0.020 |
Why?
|
Edema | 1 | 2014 | 790 | 0.020 |
Why?
|
Adolescent | 3 | 2014 | 85649 | 0.020 |
Why?
|
Aged, 80 and over | 4 | 2016 | 57683 | 0.020 |
Why?
|
Axons | 1 | 2016 | 1681 | 0.020 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2012 | 986 | 0.020 |
Why?
|
Autophagy | 1 | 2014 | 1301 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2014 | 3557 | 0.020 |
Why?
|
Regression Analysis | 1 | 2016 | 6452 | 0.020 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2014 | 2107 | 0.020 |
Why?
|
Prevalence | 1 | 2021 | 15194 | 0.020 |
Why?
|
Gene Expression | 1 | 2016 | 7790 | 0.010 |
Why?
|
Angiogenesis Inhibitors | 1 | 2013 | 2038 | 0.010 |
Why?
|
Chronic Disease | 1 | 2017 | 9144 | 0.010 |
Why?
|
Cell Survival | 1 | 2012 | 5872 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2013 | 2749 | 0.010 |
Why?
|
Acute Disease | 1 | 2013 | 7141 | 0.010 |
Why?
|
Graft Survival | 1 | 2012 | 3733 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2012 | 3584 | 0.010 |
Why?
|
Massachusetts | 1 | 2013 | 8662 | 0.010 |
Why?
|
Graft Rejection | 1 | 2012 | 4393 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2016 | 15530 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2014 | 8425 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2016 | 21719 | 0.010 |
Why?
|
Disease Progression | 1 | 2014 | 13256 | 0.010 |
Why?
|
Risk Factors | 1 | 2022 | 72145 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2013 | 7153 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2020 | 62966 | 0.010 |
Why?
|